跳至主要内容
临床试验/NL-OMON56224
NL-OMON56224招募中不适用

Tear biomarkers for Alzheimer's disease (AD) screening and diagnosis - TearAD

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Written informed consent obtained and documented
  • Capable of giving informed consent themselves (MMSE score > 17/30)*

排除标准

  • Ocular conditions that could influence tear biochemical parameters (including
  • eye infection, eye inflammation, eye surgery within the last 28 days or other
  • acute eye conditions)
  • Neurological or systemic chronic conditions known to interfere with retinal
  • thickness (e.g., glaucoma, diabetes mellitus)
  • Ocular conditions interfering with OCT quality/retinal thickness: e.g. severe
  • cataract, age-related macular degeneration, and glaucoma

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验